Literature DB >> 20016997

Platelets and innate immunity.

John W Semple1, John Freedman.   

Abstract

Although platelets are best known as primary mediators of hemostasis, this function intimately associates them with inflammatory processes, and it has been increasingly recognized that platelets play an active role in both innate and adaptive immunity. For example, platelet adhesive interactions with leukocytes and endothelial cells via P-selectin can lead to several pro-inflammatory events, including leukocyte rolling and activation, production of cytokine cascades, and recruitment of the leukocytes to sites of tissue damage. Superimposed on this, platelets express immunologically-related molecules such as CD40L and Toll-like receptors that have been shown to functionally modulate innate immunity. Furthermore, platelets themselves can interact with microorganisms, and several viruses have been shown to cross-react immunologically with platelet antigens. This review discusses the central role that platelets play in inflammation, linking them with varied pathological conditions, such as atherosclerosis, sepsis, and immune thrombocytopenic purpura, and suggests that platelets also act as primary mediators of our innate defences.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 20016997     DOI: 10.1007/s00018-009-0205-1

Source DB:  PubMed          Journal:  Cell Mol Life Sci        ISSN: 1420-682X            Impact factor:   9.261


  149 in total

1.  Neutrophil accumulation on activated, surface-adherent platelets in flow is mediated by interaction of Mac-1 with fibrinogen bound to alphaIIbbeta3 and stimulated by platelet-activating factor.

Authors:  C Weber; T A Springer
Journal:  J Clin Invest       Date:  1997-10-15       Impact factor: 14.808

Review 2.  Platelets as immune cells: bridging inflammation and cardiovascular disease.

Authors:  Philipp von Hundelshausen; Christian Weber
Journal:  Circ Res       Date:  2007-01-05       Impact factor: 17.367

Review 3.  The TREM receptor family and signal integration.

Authors:  Julia Klesney-Tait; Isaiah R Turnbull; Marco Colonna
Journal:  Nat Immunol       Date:  2006-12       Impact factor: 25.606

4.  Platelets express functional Toll-like receptor-4.

Authors:  Graciela Andonegui; Steven M Kerfoot; Kelly McNagny; Kirsten V J Ebbert; Kamala D Patel; Paul Kubes
Journal:  Blood       Date:  2005-06-16       Impact factor: 22.113

5.  PSGL-1 regulates platelet P-selectin-mediated endothelial activation and shedding of P-selectin from activated platelets.

Authors:  Vandana S Dole; Wolfgang Bergmeier; Ian S Patten; Junichi Hirahashi; Tanya N Mayadas; Denisa D Wagner
Journal:  Thromb Haemost       Date:  2007-10       Impact factor: 5.249

6.  Platelet secretion: indiscriminately spewed forth or highly orchestrated?

Authors:  G C White; R Rompietti
Journal:  J Thromb Haemost       Date:  2007-10       Impact factor: 5.824

7.  Agonists of toll-like receptor (TLR)2 and TLR4 are unable to modulate platelet activation by adenosine diphosphate and platelet activating factor.

Authors:  Jon R Ward; Lynne Bingle; Heather M Judge; Simon B Brown; Robert F Storey; Moira K B Whyte; Steven K Dower; David J Buttle; Ian Sabroe
Journal:  Thromb Haemost       Date:  2005-10       Impact factor: 5.249

8.  PADGEM protein: a receptor that mediates the interaction of activated platelets with neutrophils and monocytes.

Authors:  E Larsen; A Celi; G E Gilbert; B C Furie; J K Erban; R Bonfanti; D D Wagner; B Furie
Journal:  Cell       Date:  1989-10-20       Impact factor: 41.582

9.  Relationship of soluble CD40 ligand to vascular endothelial growth factor, angiopoietins, and tissue factor in atrial fibrillation: a link among platelet activation, angiogenesis, and thrombosis?

Authors:  Anirban Choudhury; Bethan Freestone; Jeetesh Patel; Gregory Y H Lip
Journal:  Chest       Date:  2007-12       Impact factor: 9.410

10.  Activated platelets mediate inflammatory signaling by regulated interleukin 1beta synthesis.

Authors:  S Lindemann; N D Tolley; D A Dixon; T M McIntyre; S M Prescott; G A Zimmerman; A S Weyrich
Journal:  J Cell Biol       Date:  2001-08-06       Impact factor: 10.539

View more
  93 in total

Review 1.  Clinical relevance of microparticles from platelets and megakaryocytes.

Authors:  Joseph E Italiano; Albert T A Mairuhu; Robert Flaumenhaft
Journal:  Curr Opin Hematol       Date:  2010-11       Impact factor: 3.284

2.  Human platelet FcγRIIA and phagocytes in immune-complex clearance.

Authors:  Zhen-Yu Huang; Paul Chien; Zena K Indik; Alan D Schreiber
Journal:  Mol Immunol       Date:  2010-12-17       Impact factor: 4.407

Review 3.  Platelets as central mediators of systemic inflammatory responses.

Authors:  Tammy L Smith; Andrew S Weyrich
Journal:  Thromb Res       Date:  2010-11-11       Impact factor: 3.944

4.  S6K1 and mTOR regulate Rac1-driven platelet activation and aggregation.

Authors:  Joseph E Aslan; Garth W Tormoen; Cassandra P Loren; Jiaqing Pang; Owen J T McCarty
Journal:  Blood       Date:  2011-07-14       Impact factor: 22.113

5.  Influenza-induced thrombocytopenia is dependent on the subtype and sialoglycan receptor and increases with virus pathogenicity.

Authors:  A J Gerard Jansen; Thom Spaan; Hui Zhi Low; Daniele Di Iorio; Judith van den Brand; Malte Tieke; Arjan Barendrecht; Kerstin Rohn; Geert van Amerongen; Koert Stittelaar; Wolfgang Baumgärtner; Albert Osterhaus; Thijs Kuiken; Geert-Jan Boons; Jurriaan Huskens; Marianne Boes; Coen Maas; Erhard van der Vries
Journal:  Blood Adv       Date:  2020-07-14

Review 6.  Platelets: versatile effector cells in hemostasis, inflammation, and the immune continuum.

Authors:  Adriana Vieira-de-Abreu; Robert A Campbell; Andrew S Weyrich; Guy A Zimmerman
Journal:  Semin Immunopathol       Date:  2011-08-06       Impact factor: 9.623

Review 7.  Interactions between coagulation and complement--their role in inflammation.

Authors:  Katerina Oikonomopoulou; Daniel Ricklin; Peter A Ward; John D Lambris
Journal:  Semin Immunopathol       Date:  2011-08-03       Impact factor: 9.623

Review 8.  Platelets and pathogens.

Authors:  Kenneth J Clemetson
Journal:  Cell Mol Life Sci       Date:  2009-11-21       Impact factor: 9.261

9.  State of the art in platelet function testing.

Authors:  Beate E Kehrel; Martin F Brodde
Journal:  Transfus Med Hemother       Date:  2013-03-18       Impact factor: 3.747

10.  Prasugrel metabolites inhibit neutrophil functions.

Authors:  Elisabetta Liverani; Mario C Rico; Analia E Garcia; Laurie E Kilpatrick; Satya P Kunapuli
Journal:  J Pharmacol Exp Ther       Date:  2012-10-24       Impact factor: 4.030

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.